Penile Cancer and Rare Urogenital Malignancies: From Biology to Clinical Management
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 15 July 2026 | Viewed by 18
Special Issue Editors
Interests: urology; urologic cancers; kidney cancer; penile cancer; reconstructive urology; lichen sclerosus; penile diseases
Special Issue Information
Dear Colleagues,
Rare urogenital malignancies, such as penile cancer, upper tract urothelial carcinoma (UTUC), primary urethral carcinoma, and tumors of the penile skin or scrotum, present significant diagnostic and therapeutic challenges for clinicians. Their low prevalence has resulted in a scarcity of comprehensive data, which has impeded the establishment of standardized care protocols. This Special Issue will consolidate the current evidence on molecular biology, inflammation-driven mechanisms, microbial influences, and clinical outcomes. We invite the submission of original research, narrative or systematic reviews that address surgical management, systemic therapies, epidemiology, and prognostic biomarkers in this disease. By fostering interdisciplinary insights, we aim to enhance clinical decision-making and advance effective individualized treatment approaches in these uncommon but impactful genitourinary cancers.
Dr. Mateusz Czajkowski
Prof. Dr. Marcin Matuszewski
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- penile cancer
- urethral carcinoma
- upper tract urothelial carcinoma
- rare urogenital tumors
- surgical management
- systemic therapy
- epidemiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
